PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
30-Jun-2022 Phacilitate announces the inauguration of First Gala Awards Dinner to celebrate the achievements of the advanced therapies field Phacilitate
30-Jun-2022 Amolyt Pharma Strengthens Leadership Team with Appointment of Mark Sumeray, M.D., as Chief Medical Officer Amolyt Pharma 
30-Jun-2022 Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
30-Jun-2022 International Centers for Precision Oncology International Centers for Precision Oncology
30-Jun-2022 Mental Health Market is estimated to be US$ 527.44 billion by 2030 with a CAGR of 3.40% during the forecast period Prophecy Market Insights
30-Jun-2022 Virology Market worth US$ 3.7 Billion 2030 with a CAGR of 9.9% Prophecy market insights
29-Jun-2022 PHASTAR Names Chris Schoonmaker as Chief Operations Officer PHASTAR
29-Jun-2022 North America’s Largest lntegrated Research Site Organization, Centricity Research, Expands Further with Addition of Aventiv Research c/o Centricity Research
28-Jun-2022 Pistoia Alliance Project Digitizes Sharing of Analytical Methods Data to Support Machine Learning and Boost Cyber Resilience Pistoia Alliance
28-Jun-2022 ProQR to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium ProQR
28-Jun-2022 Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions Terumo Blood
27-Jun-2022 Valo Therapeutics Appoints Experienced Life Sciences Executive Anthony Giovinazzo to Board Valo Therapeutics
27-Jun-2022 CGI establishes National Advisory Board to support resolution of major health and care challenges across the UK CGI
27-Jun-2022 Ixaka and Minaris Regenerative Medicine Sign Tech Transfer and GMP Manufacturing Agreement for Lead Cell Therapy Candidate REX-001 Ixaka
27-Jun-2022 EMA recommends olaparib for treatment of high-risk, early breast cancer The Institute of Cancer Research, London
27-Jun-2022 Transgene and BioInvent announce positive progress for BT-001 Transgene
27-Jun-2022 Immutep to announce new TACTI-002 data at the 2022 World Conference on Lung Cancer Immutep
27-Jun-2022 ViroBlock, a Hebrew University Startup, Announces Preliminary Success of its Anti-Viral Drug Platform in New Study ViroBlock
27-Jun-2022 Phacilitate announces the inauguration of First Gala Awards Dinner to celebrate the achievements of the advanced therapies field Phacilitate
24-Jun-2022 Albireo Presents New Bylvay® (odevixibat) Data at Annual ESPGHAN Congress Albireo Pharma